Treatment : symptomatic therapy
In the pre-specified in-study analysis based on pooled 9 mg and 12 mg retatrutide groups, 44 participants receiving retatrutide experienced a MACE-5 event, defined as all-cause death, myocardial infarction, stroke, heart failure event, or coronary revascularization, compared with 52 participants receiving placebo, corresponding to a hazard ratio of 0.82 (95% CI: 0.55-1.22)
Our personalized programs are designed to help you achieve sustainable results while improving energy and body composition
6. Pigmented & Buildable Color
Its the first FDA-approved drug since 2014 for chronic weight management in overweight or obese adults
Anti-Inflammatory Properties BPC-157 Peptides exhibit anti-inflammatory properties, which contribute to their appeal in research scenarios